Phase 1 Age related macular degeneration (AMD) Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Safety and Efficacy of Oral HX9428 Tablets in Subjects With Wet Age-related Macular Degeneration (wAMD)

wet age related macular degeneration (AMD)

Fujian Haixi Pharmaceuticals Co., Ltd.198 enrolled1 locationNCT07185841

Completed

Phase 1

A Phase 1b, Open-Label, Parallel Single-Dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Tinlarebant in Healthy Volunteers Aged 50-85

Dry Age related macular degeneration (AMD)

RBP4 Pty Ltd16 enrolled1 locationACTRN12622001520729